<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font15">were </span>
   <span class="font15">for </span>
   <span class="font14">was </span>
   <span class="font13">The </span>
   <span class="font13">with </span>
   <span class="font13">patients </span>
   <span class="font13">that </span>
   <span class="font13">antiviral </span>
   <span class="font12">{background </span>
   <span class="font12">therapy </span>
   <span class="font12">treatment </span>
   <span class="font12">HBV </span>
   <span class="font12">hepatitis </span>
   <span class="font12">not </span>
   <span class="font11">margin </span>
   <span class="font11">studies </span>
   <span class="font11">are </span>
   <span class="font11">{border-style </span>
   <span class="font11">analysis </span>
   <span class="font11">study </span>
   <span class="font11">():–. </span>
   <span class="font11">px;} </span>
   <span class="font11">trials </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Hepatitis </span>
   <span class="font11">had </span>
   <span class="font11">remission </span>
   <span class="font11">HBeAg </span>
   <span class="font11">Medicine </span>
   <span class="font11">all </span>
   <span class="font11">renal </span>
   <span class="font11">CI: </span>
   <span class="font11">proteinuria </span>
   <span class="font11">than </span>
   <span class="font11">Fig </span>
   <span class="font11">could </span>
   <span class="font11">data </span>
   <span class="font11">effects </span>
   <span class="font11">included </span>
   <span class="font11">virus-associated </span>
   <span class="font11">Health </span>
   <span class="font11">IFNs </span>
   <span class="font11">clinical </span>
   <span class="font11">from </span>
   <span class="font11">our </span>
   <span class="font11">which </span>
   <span class="font11">(OR </span>
   <span class="font11">Sciences </span>
   <span class="font11">but </span>
   <span class="font11">efficacy </span>
   <span class="font11">pediatric </span>
   <span class="font11">Clinical </span>
   <span class="font11">HBV-GN </span>
   <span class="font11">bias </span>
   <span class="font11">performed </span>
   <span class="font11">study[] </span>
   <span class="font10">adult </span>
   <span class="font10">al[] </span>
   <span class="font10">group </span>
   <span class="font10">heterogeneity </span>
   <span class="font10">patients. </span>
   <span class="font10">showed </span>
   <span class="font10">test </span>
   <span class="font10">total </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Journal </span>
   <span class="font10">clearance </span>
   <span class="font10">eGFR </span>
   <span class="font10">effect </span>
   <span class="font10">follow-up </span>
   <span class="font10">have </span>
   <span class="font10">more </span>
   <span class="font10">rate </span>
   <span class="font10">results </span>
   <span class="font10">review </span>
   <span class="font10">they </span>
   <span class="font10">type </span>
   <span class="font10">virus </span>
   <span class="font10">after </span>
   <span class="font10">analyses </span>
   <span class="font10">anti-viral </span>
   <span class="font10">chronic </span>
   <span class="font10">did </span>
   <span class="font10">different </span>
   <span class="font10">drug </span>
   <span class="font10">model </span>
   <span class="font10">nephropathy </span>
   <span class="font10">one </span>
   <span class="font10">px; </span>
   <span class="font10">sensitivity </span>
   <span class="font10">significant </span>
   <span class="font10">these </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">Cochrane </span>
   <span class="font10">DNA </span>
   <span class="font10">However, </span>
   <span class="font10">Subgroup </span>
   <span class="font10">age </span>
   <span class="font10">also </span>
   <span class="font10">can </span>
   <span class="font10">drugs </span>
   <span class="font10">duration </span>
   <span class="font10">effective </span>
   <span class="font10">evaluated </span>
   <span class="font10">font-size </span>
   <span class="font10">odds </span>
   <span class="font10">other </span>
   <span class="font10">outcome </span>
   <span class="font10">serum </span>
   <span class="font10">side </span>
   <span class="font10">subgroup </span>
   <span class="font10">used </span>
   <span class="font10">(Fig </span>
   <span class="font10">Biology </span>
   <span class="font10">CCT </span>
   <span class="font10">Chinese </span>
   <span class="font10">Click </span>
   <span class="font10">LINK </span>
   <span class="font10">NAs </span>
   <span class="font10">NAs. </span>
   <span class="font10">OR: </span>
   <span class="font10">additional </span>
   <span class="font10">adverse </span>
   <span class="font10">al.[] </span>
   <span class="font10">between </span>
   <span class="font10">complete </span>
   <span class="font10">control </span>
   <span class="font10">controlled </span>
   <span class="font10">double; </span>
   <span class="font10">file. </span>
   <span class="font10">glomerular </span>
   <span class="font10">glomerulonephritis </span>
   <span class="font10">here </span>
   <span class="font10">heterogeneity. </span>
   <span class="font10">may </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">only </span>
   <span class="font10">patients, </span>
   <span class="font10">remission. </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(/, </span>
   <span class="font10">(TIF) </span>
   <span class="font10">.−.). </span>
   <span class="font10">All </span>
   <span class="font10">China </span>
   <span class="font10">Our </span>
   <span class="font10">Therapy </span>
   <span class="font10">This </span>
   <span class="font10">Treatment </span>
   <span class="font10">articles </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">evaluate </span>
   <span class="font10">fixed-effect </span>
   <span class="font10">groups </span>
   <span class="font10">including </span>
   <span class="font10">infection </span>
   <span class="font10">most </span>
   <span class="font10">pathogens </span>
   <span class="font10">pathological </span>
   <span class="font10">random </span>
   <span class="font10">risk </span>
   <span class="font10">safety </span>
   <span class="font10">solid; </span>
   <span class="font10">such </span>
   <span class="font10">terms </span>
   <span class="font10">trial </span>
   <span class="font10">trials. </span>
   <span class="font10">two </span>
   <span class="font10">viral </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.%), </span>
   <span class="font10">.±. </span>
   <span class="font10">.−.) </span>
   <span class="font10">.−., </span>
   <span class="font10">American </span>
   <span class="font10">CR: </span>
   <span class="font10">Controlled </span>
   <span class="font10">Gastroenterology. </span>
   <span class="font10">IFNs, </span>
   <span class="font10">International </span>
   <span class="font10">Kidney </span>
   <span class="font10">Nephrology. </span>
   <span class="font10">PRISMA </span>
   <span class="font10">Randomized </span>
   <span class="font10">Research </span>
   <span class="font10">Study </span>
   <span class="font10">Sun </span>
   <span class="font10">Sun’s </span>
   <span class="font10">Trials </span>
   <span class="font10">Viral </span>
   <span class="font10">antigen </span>
   <span class="font10">article </span>
   <span class="font10">based </span>
   <span class="font10">because </span>
   <span class="font10">bold </span>
   <span class="font10">cohort </span>
   <span class="font10">courier; </span>
   <span class="font10">data. </span>
   <span class="font10">differences </span>
   <span class="font10">eligible </span>
   <span class="font10">em; </span>
   <span class="font10">events </span>
   <span class="font10">filtration </span>
   <span class="font10">focused </span>
   <span class="font10">found </span>
   <span class="font10">glomerulonephritis. </span>
   <span class="font10">glomerulonephritis: </span>
   <span class="font10">higher </span>
   <span class="font10">immune </span>
   <span class="font10">mainly </span>
   <span class="font10">membranous </span>
   <span class="font10">mentioned </span>
   <span class="font10">original </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">ratio; </span>
   <span class="font10">regarding </span>
   <span class="font10">related </span>
   <span class="font10">replication </span>
   <span class="font10">secondary </span>
   <span class="font10">sensitive </span>
   <span class="font10">significantly </span>
   <span class="font10">studies, </span>
   <span class="font10">symptoms </span>
   <span class="font10">systematic </span>
   <span class="font10">their </span>
   <span class="font10">treated </span>
   <span class="font10">trials, </span>
  </p>
 </body>
</html>
